Kamada director granted 30,000 stock options
Kamada Ltd director Lilach Payorski received an employee stock option grant on August 5, 2026 for 30,000 options, each exercisable into one ordinary share at an exercise price of $7.52 per share, converted from NIS.
Rhea-AI Filing Summary
Kamada Ltd director Lilach Payorski received an employee stock option grant on August 5, 2026 for 30,000 options, each exercisable into one ordinary share at an exercise price of $7.52 per share, converted from NIS. The options vest in four equal annual installments over four years, are exercisable for 10 years, and are held indirectly by a trustee under the company’s 2011 Share Award Plan, leaving Payorski with 30,000 options after this award.
Positive
- None.
Negative
- None.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Employee Stock Option (right to buy) F1, F2, F3 | 30,000 | $0.00 | $0.00 |
Footnotes (3)
- F1. The exercise price presented in U.S. dollars represent a convenience conversion from NIS based on the exchange rate published by the Bank of Israel as of August 4, 2026.
- F2. The options will vest over a period of four years in four equal installments, such that 25% of the options will vest on each anniversary of the grant date. The options will be exercisable for a period of 10 years following the date of grant, and all unexercised options will expire immediately thereafter.
- F3. Held by trustee under the Company's 2011 Share Award Plan.
Key Figures
Key Terms
Employee Stock Option financial
exercise price financial
vest over a period of four years financial
Held by trustee financial
indirect financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction did Kamada (KMDA) disclose for Lilach Payorski?
What is the exercise price of Lilach Payorski’s Kamada (KMDA) stock options?
How do Lilach Payorski’s Kamada (KMDA) options vest and when do they expire?
How are Lilach Payorski’s Kamada (KMDA) options held and classified?
Were Lilach Payorski’s Kamada (KMDA) option grants under a Rule 10b5-1 plan?
AI-generated analysis. How Rhea-AI works. Not financial advice.